AAAAAA

   
Results: 1-9 |
Results: 9
Use of broad spectrum antibiotics in six non-university Swiss hospitals
Authors: von Gunten, V Reymond, JP Troillet, N
Citation: V. Von Gunten et al., Use of broad spectrum antibiotics in six non-university Swiss hospitals, SWISS MED W, 131(29-30), 2001, pp. 438-441
Usefulness of procalcitonin serum level for the diagnosis of bacteremia
Authors: Liaudat, S Dayer, E Praz, G Bille, J Troillet, N
Citation: S. Liaudat et al., Usefulness of procalcitonin serum level for the diagnosis of bacteremia, EUR J CL M, 20(8), 2001, pp. 524-527
Effects of yellow fever vaccination
Authors: Troillet, N Laurencet, F
Citation: N. Troillet et F. Laurencet, Effects of yellow fever vaccination, LANCET, 358(9296), 2001, pp. 1908-1909
Efavirenz decreases methadone blood concentrations
Authors: Marzolini, C Troillet, N Telenti, A Baumann, P Decosterd, LA Eap, CB
Citation: C. Marzolini et al., Efavirenz decreases methadone blood concentrations, AIDS, 14(9), 2000, pp. 1291-1292
Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence
Authors: Blanc, DS Petignat, C Moreillon, P Entenza, JM Eisenring, MC Kleiber, H Wenger, A Troillet, N Blanc, CH Francioli, P
Citation: Ds. Blanc et al., Unusual spread of a penicillin-susceptible methicillin-resistant Staphylococcus aureus clone in a geographic area of low incidence, CLIN INF D, 29(6), 1999, pp. 1512-1518
Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients
Authors: Troillet, N Carmeli, Y Venkataraman, L DeGirolami, P Samore, MH
Citation: N. Troillet et al., Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients, J HOSP INF, 42(1), 1999, pp. 37-43
Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents
Authors: Carmeli, Y Troillet, N Eliopoulos, GM Samore, MH
Citation: Y. Carmeli et al., Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents, ANTIM AG CH, 43(6), 1999, pp. 1379-1382
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (vol 42, pg 2966, 1998)
Authors: Jaccard, C Troillet, N Harbarth, S Zanetti, G Aymon, D Schneider, R Chiolero, R Ricou, B Romand, J Huber, O Ambrosetti, P Praz, G Lew, D Bille, J Glauser, MP Comett, A
Citation: C. Jaccard et al., Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis (vol 42, pg 2966, 1998), ANTIM AG CH, 43(3), 1999, pp. 726-726
Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
Authors: Carmeli, Y Troillet, N Karchmer, AW Samore, MH
Citation: Y. Carmeli et al., Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa, ARCH IN MED, 159(10), 1999, pp. 1127-1132
Risultati: 1-9 |